# Ligand Pharmaceuticals, Inc. (LGNDZ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LGNDZ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 115.42M | $ 35.16M | $ 72.46M | $ 1.13B | $ 967.52M |
| 2025 | $ 274.50M | $ 127.43M | $ 50.08M | $ 451.49M | $ 1.02B |
| 2024 | $ 175.67M | $ -4.24M | $ 100.09M | $ 7.11M | $ 830.44M |
| 2023 | $ 141.98M | $ 56.39M | $ -5.65M | $ 6.17M | $ 700.91M |
| 2022 | $ 245.30M | $ -37.27M | $ 133.97M | $ 87.75M | $ 597.49M |
| 2021 | $ 329.41M | $ 68.45M | $ 83.25M | $ 338.31M | $ 821.16M |
| 2020 | $ 385.81M | $ -27.46M | $ -71.20M | N/A | $ 709.53M |
| 2019 | $ 155.25M | $ 812.27M | $ -150.74M | $ 648.93M | $ 767.23M |
| 2018 | $ 332.09M | $ 189.28M | $ 206.24M | $ 636.30M | $ 560.91M |
| 2017 | $ 190.08M | $ 137.28M | $ 95.60M | $ 243.39M | $ 399.79M |
| 2016 | $ 149.93M | $ 25.16M | $ 70.18M | $ 242.47M | $ 341.29M |
| 2015 | $ 100.97M | $ -258.72M | $ 51.08M | $ 241.61M | $ 237.28M |
| 2014 | $ 91.19M | $ 16.55M | $ 24.89M | $ 199.53M | $ 26.32M |
| 2013 | $ 69.65M | $ 16.24M | $ 29.69M | $ 5.88M | $ 49.61M |
| 2012 | $ 45.32M | $ 612.2K | $ 672.8K | $ 9.00M | $ 26.49M |
| 2011 | $ 44.13M | $ 14.95M | $ -1.84M | $ 8.37M | $ 8.65M |
| 2010 | $ 35.64M | $ -15.71M | $ -41.45M | $ 11.12M | $ -4.85M |
| 2009 | $ 58.96M | $ -2.95M | $ -47.18M | $ 0 | $ 3.74M |
| 2008 | $ 41.36M | $ -148.56M | $ 0 | $ 2.18M | $ -10.37M |
| 2007 | $ 19.52M | $ 426.52M | $ -148.64M | $ 627.0K | $ 29.12M |
| 2006 | $ 213.43M | $ -322.04M | $ -212.44M | $ 39.91M | $ 27.35M |
| 2005 | N/A | N/A | $ 0 | N/A | N/A |
| 2004 | N/A | N/A | $ 3.26M | N/A | N/A |
| 2003 | N/A | N/A | $ -3.80M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.16 |
| Liabilities / Eq | 1.26 |
| Current Ratio | 30.49 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 8.45 |
| Gross Debt / FCF | 27.96 |

## Other views

- [Metrics](https://sponda.capital/en/LGNDZ.md)
- [Charts](https://sponda.capital/en/LGNDZ/charts.md)
- [Compare](https://sponda.capital/en/LGNDZ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.